Skip to main content

Fiscal Wizard · Single-issue tearsheet

BBNX / Jun 21, 2026 Run #7423

BBNX

Beta Bionics, Inc.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.

Composite verdict

F 26.9 / 100
Bearish setup · Mean Reversion 7 drivers · 2 gates blocking
  • Stochastic Cross
  • Engulfing
  • Bollinger Reentry
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 52nd of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: downtrend
Bull 0%Evidence: High · 17 signals100% Bear
Momentum Neutral 46Mean-reversion Bearish 15

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -99%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Mixed

45.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Revenue Growth (YoY) 100
Free Cash Flow Yield 0
Gross Margin 75
Cash Conversion Cycle 0

Technicals Bearish

8.2 / 100

Bearish setup leads (Stochastic Cross, Engulfing, Bollinger Reentry); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Stochastic Cross 11
Engulfing 15
Bollinger Reentry 17

Risk Gates

2 blocking 6 caution

2 guards active, 23 signals gated.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for BBNX.